EP2076126A4 - Nouvelles combinaisons d'inhibiteurs de dnak avec des agents antibactériens connus - Google Patents

Nouvelles combinaisons d'inhibiteurs de dnak avec des agents antibactériens connus

Info

Publication number
EP2076126A4
EP2076126A4 EP06824922A EP06824922A EP2076126A4 EP 2076126 A4 EP2076126 A4 EP 2076126A4 EP 06824922 A EP06824922 A EP 06824922A EP 06824922 A EP06824922 A EP 06824922A EP 2076126 A4 EP2076126 A4 EP 2076126A4
Authority
EP
European Patent Office
Prior art keywords
dnak
inhibitors
antibacterial agents
novel combinations
known antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06824922A
Other languages
German (de)
English (en)
Other versions
EP2076126A1 (fr
Inventor
Michael Alan Sturgess
Kenneth E Kovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHAPERONE TECHNOLOGIES Inc
Original Assignee
CHAPERONE TECHNOLOGIES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHAPERONE TECHNOLOGIES Inc filed Critical CHAPERONE TECHNOLOGIES Inc
Publication of EP2076126A1 publication Critical patent/EP2076126A1/fr
Publication of EP2076126A4 publication Critical patent/EP2076126A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP06824922A 2006-09-12 2006-09-12 Nouvelles combinaisons d'inhibiteurs de dnak avec des agents antibactériens connus Withdrawn EP2076126A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/035272 WO2008033119A1 (fr) 2006-09-12 2006-09-12 Nouvelles combinaisons d'inhibiteurs de dnak avec des agents antibactériens connus

Publications (2)

Publication Number Publication Date
EP2076126A1 EP2076126A1 (fr) 2009-07-08
EP2076126A4 true EP2076126A4 (fr) 2011-12-28

Family

ID=39184060

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06824922A Withdrawn EP2076126A4 (fr) 2006-09-12 2006-09-12 Nouvelles combinaisons d'inhibiteurs de dnak avec des agents antibactériens connus

Country Status (2)

Country Link
EP (1) EP2076126A4 (fr)
WO (1) WO2008033119A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078956A1 (fr) * 1999-06-23 2000-12-28 The Wistar Institute Of Anatomy And Biology Nouveaux peptides derives de pyrrhocoricine et leurs procedes de mise en application
US20030108957A1 (en) * 2002-07-19 2003-06-12 The Wistar Institute Of Anatomy And Biology Biocidal molecules, macromolecular targets and methods of production and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
EP1657249A1 (fr) * 2004-11-10 2006-05-17 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Dérivés antibiotiques de la drosocine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078956A1 (fr) * 1999-06-23 2000-12-28 The Wistar Institute Of Anatomy And Biology Nouveaux peptides derives de pyrrhocoricine et leurs procedes de mise en application
US20030108957A1 (en) * 2002-07-19 2003-06-12 The Wistar Institute Of Anatomy And Biology Biocidal molecules, macromolecular targets and methods of production and use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CUDIC M ET AL: "In vitro and in vivo activity of an antibacterial peptide analog against uropathogens", PEPTIDES, ELSEVIER, AMSTERDAM, vol. 24, 1 January 2003 (2003-01-01), pages 807 - 820, XP002329691, ISSN: 0196-9781, DOI: 10.1016/S0196-9781(03)00172-4 *
See also references of WO2008033119A1 *
YAMAGUCHI YUKO ET AL: "Effects of disruption of heat shock genes on susceptibility of Escherichia coli to fluoroquinolones", BMC MICROBIOLOGY, BIOMED CENTRAL, LONDON, GB, vol. 3, no. 1, 12 August 2003 (2003-08-12), pages 16, XP021002539, ISSN: 1471-2180, DOI: 10.1186/1471-2180-3-16 *

Also Published As

Publication number Publication date
EP2076126A1 (fr) 2009-07-08
WO2008033119A1 (fr) 2008-03-20

Similar Documents

Publication Publication Date Title
HUS2000024I1 (hu) Béta laktamáz inhibitorok
IL195031A0 (en) Uses of dpp-iv inhibitors
PL2361922T3 (pl) Produkty pośrednie do wytwarzania inhibitorów nukleozydowych HCV
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
IL199019A0 (en) Acylaminopyrazoles as fgfr inhibitors
IL211018A0 (en) Novel inhibitors
IL200153A0 (en) Novel phosphodiesterase inhibitors
EP2059126A4 (fr) Composition antimicrobienne contenant de l'isothiazolin-3-one
IL196883A0 (en) Antibiotic composition
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
GB0621607D0 (en) Inhibitors of c-Met
EP2296476A4 (fr) Inhibiteurs de la formation de biofilm bactérien
ZA200905371B (en) Novel phosphodiesterase Inhibitors
GB0714941D0 (en) Inhibitors
GB0621107D0 (en) Inhibitors of phosphodiesterase-4
GB0707493D0 (en) Novel inhibitors
GB0707495D0 (en) Novel inhibitors
GB0704589D0 (en) Novel inhibitors
GB0707488D0 (en) Novel inhibitors
GB0707498D0 (en) Novel inhibitors
GB0707499D0 (en) Novel inhibitors
GB0707497D0 (en) Novel inhibitors
GB0707632D0 (en) Novel inhibitors
GB0621980D0 (en) Inhibitors of c-Met
GB0816125D0 (en) Novel inhibitors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090414

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20111129

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/04 20060101ALI20111123BHEP

Ipc: A01N 37/18 20060101AFI20111123BHEP

Ipc: A61K 38/10 20060101ALI20111123BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120403